These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8215478)
1. [Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for the prophylactic treatment of emesis induced by cisplatin-containing chemotherapy]. Tsukuda M; Kokatsu T; Furukawa S; Kohno H; Kubota A; Furukawa M; Enomoto H Gan To Kagaku Ryoho; 1993 Oct; 20(13):2037-41. PubMed ID: 8215478 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of granisetron alone and granisetron plus dexamethasone or hydroxyzine hydrochloride for the prevention of nausea and vomiting during chemotherapy including cisplatin]. Tsukuda M; Kohno H; Enomoto H; Kawai S; Yago T; Matsuda H; Ikema Y; Makino Y; Kubota A; Furukawa M Gan To Kagaku Ryoho; 1995 Sep; 22(10):1377-82. PubMed ID: 7668873 [TBL] [Abstract][Full Text] [Related]
3. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial. Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488 [TBL] [Abstract][Full Text] [Related]
4. Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for prophylactic treatment of emesis induced by cisplatin chemotherapy. Tsukuda M; Furukawa S; Kokatsu T; Enomoto H; Kubota A; Furukawa M Eur J Cancer; 1995 Sep; 31A(10):1647-9. PubMed ID: 7488417 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer]. Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J Gan To Kagaku Ryoho; 1997 Jul; 24(9):1095-101. PubMed ID: 9239162 [TBL] [Abstract][Full Text] [Related]
6. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer]. Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306 [TBL] [Abstract][Full Text] [Related]
7. [A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Nara Medical University Kytril Study Group]. Ozono S; Okajima E; Hirao YK; Natsume O; Kaneko Y; Ohara S; Tabata S; Watanabe S; Aoyama H; Sasaki K; Matsuki H; Takashima K; Maruyama Y; Yoshikawa M; Yamada K; Momose H; Hiramatsu T; Hayashi Y; Babaya K; Shiomi T Gan To Kagaku Ryoho; 1997 Feb; 24(3):349-56. PubMed ID: 9051139 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Study Group]. Uchida K; Akaza H; Shimazui T; Kikuchi K; Manabe F; Iwasaki A; Ishikawa S; Noguchi R; Otani M; Hattori K; Kondo F; Nishijima Y; Sato K; Koiso K; Hinotsu S Gan To Kagaku Ryoho; 1996 Jan; 23(1):81-6. PubMed ID: 8546475 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy. Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429 [TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy. Ettinger DS; Eisenberg PD; Fitts D; Friedman C; Wilson-Lynch K; Yocom K Cancer; 1996 Jul; 78(1):144-51. PubMed ID: 8646710 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy. Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505 [TBL] [Abstract][Full Text] [Related]
12. [Clinical effects and safety of granisetron administration against CDDP chemotherapy in lung cancer. Lung Cancer Study Group]. Hamada T; Kuwahara T; Ida M; Hayasaka S; Yoshinaga T; Kawano S; Ushijima M; Matsumura K; Ueda K; Nomura H Gan To Kagaku Ryoho; 1994 Aug; 21(10):1647-53. PubMed ID: 8060141 [TBL] [Abstract][Full Text] [Related]
13. [The prevention of cancer chemotherapy-induced emesis with granisetron and clonazepam]. Eguchi F; Shindo M; Emoto M; Mohtai H; Hachisuga T; Kawarabayashi T; Shirakawa K Gan To Kagaku Ryoho; 1995 Feb; 22(2):233-7. PubMed ID: 7857098 [TBL] [Abstract][Full Text] [Related]
14. [Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer chemotherapy]. Hisano C; Nakano S; Okuma K; Masumoto N; Fujishima H; Nakamura M; Niho Y Gan To Kagaku Ryoho; 1996 Aug; 23(9):1175-81. PubMed ID: 8751806 [TBL] [Abstract][Full Text] [Related]
15. Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis. Martoni A; Piana E; Strocchi E; Angelelli B; Guaraldi M; Zamagni C; Camaggi CM; Pannuti F Anticancer Res; 1998; 18(4B):2799-803. PubMed ID: 9713464 [TBL] [Abstract][Full Text] [Related]
16. [Granisetron versus granisetron plus methylprednisolone in the prevention of chemotherapy induced nausea and vomiting--in adjuvant chemotherapy, including CDDP against gastric cancer]. Kurita A; Takashima S; Nakata M; Kubo Y; Saiki T; Ohsumi S; Yokoyama N; Tanada M; Takiyama W; Saeki H Gan To Kagaku Ryoho; 1997 Jan; 24(1):49-54. PubMed ID: 9020945 [TBL] [Abstract][Full Text] [Related]
17. [Antiemetic efficacy of granisetron in pediatric cancer treatment--(2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis]. Hirota T; Honjo T; Kuroda R; Saeki K; Katano N; Sakakibara Y; Shimizu H; Fujimoto T Gan To Kagaku Ryoho; 1993 Dec; 20(15):2369-73. PubMed ID: 8259853 [TBL] [Abstract][Full Text] [Related]
18. [Comparative trial of granisetron versus granisetron plus methylprednisolone for the prevention of nausea and vomiting induced by cancer chemotherapy]. Hirota T; Shimizu H; Fujimoto T; Koike A; Kojima T; Noguchi M; Yabushita H; Kato R; Daimaru O; Noda A Gan To Kagaku Ryoho; 1994 Jan; 21(1):91-6. PubMed ID: 8291920 [TBL] [Abstract][Full Text] [Related]
19. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting. Voravud N; Sriuranpong V J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975 [TBL] [Abstract][Full Text] [Related]
20. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial. Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]